1527 / 1544
IMRT
may provide
dosimetric and possibly clinical
advantages in radiotherapy treatment to some (possibly
most or even all) patients with NSCLC being considered for high-dose
potentially curative radiotherapy.
Current data are insufficient
to fully determine the clinical, or even the
dosimetric, advantage of IMRT, except that all data seem to point
towards the advantage of IMRT over 3DCRT
Clin Oncol (Roy Coll Radiol), 2012